Update on Fever of Unknown Origin in Children: Focus on Etiologies and Clinical Approach.
Sandra Trapani, Adele Fiordelisi, Mariangela Stinco...
https://pubmed.ncbi.nlm.nih.gov/38255334/Actively Recruiting
Led by University of Texas at Austin · Updated on 2025-07-20
440
Participants Needed
1
Research Sites
10 weeks
Total Duration
Researchers are evaluating whether providing parents with a prescription for the correct weight-based doses of acetaminophen and ibuprofen reduces unscheduled return visits to the emergency department ED within one week for children evaluated for fever. This study focuses on children aged 6 to less than 36 months who are discharged from a pediatric ED. The goal is to understand if prescribing these common fever medicines affects return visits, patient satisfaction, and overall healthcare use. The study is a single-center, randomized controlled trial at a pediatric ED. Participants will be randomly assigned either to an intervention group that receives prescriptions for acetaminophen and ibuprofen with weight-based dosing or to a control group that receives standard printed discharge instructions including dosing information but no prescription. Both groups get the usual discharge education. The study involves 220 children in each group. After discharge, research staff will follow up by phone one week later to check if families made any unscheduled visits to the ED, urgent care, or clinics for similar complaints. They will also assess parental satisfaction with the care received. The main measure is whether an unscheduled return visit occurred within seven days. Secondary measures include total return visits, hospital admissions, and satisfaction levels. Caregivers will be informed about group assignment and asked for permission to continue using collected data for research.
CONDITIONS
Prescription Antipyretics to Decrease Unscheduled Return Visits In A Pediatric Emergency Department
L
Lina Palomares, RN, LMSW
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Texas at Austin
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Prescription‑based dosing | Standard discharge guidance | Current guideline practice |
|---|---|---|---|
| What it is | A written prescription at discharge that specifies weight‑based dosing for acetaminophen and ibuprofen. | Standard printed discharge instructions including appropriate dosing for acetaminophen and ibuprofen without a prescription. | Weight‑based dosing of acetaminophen or ibuprofen is recommended for outpatient fever management in children. |
| Role in trial | Investigational discharge practice being tested to reduce unscheduled return visits. | Control arm reflecting current practice of providing discharge instructions only. | Represents how antipyretics are currently dosed in outpatient pediatric practice. |
| Primary use | To reduce unscheduled return visits by ensuring accurate dosing via prescription. | To guide caregivers with dosing instructions via printed materials only. | To manage fever by guiding caregivers to use weight‑based antipyretics appropriately in the outpatient setting. |
| How it is given or performed | Providers give a written prescription for acetaminophen and ibuprofen with dosing instructions adjusted to the child’s weight. | Caregivers receive printed instructions showing the appropriate dose of acetaminophen and ibuprofen based on age or general standards. | Caregivers measure dose using weight‑based charts or devices according to guidelines. |
| Evidence status | Effectiveness on reducing return visits is being studied and not yet known. | Effectiveness as current practice baseline is not established by trial yet. | Weight‑based dosing is widely accepted but evidence on effect on return visits specifically is not defined. |
| Important risks | Potential risk of dosing errors remains if caregivers misinterpret weight‑based instructions. | Risk of inaccurate dosing exists if instructions are misread or not followed. | Guidelines emphasize simplified dosing tools to reduce errors. |
| Important limitations | May not reduce return visits if caregivers still misunderstand instructions, and requires prescription access. | Printed instructions alone may not ensure correct dosing by weight. | Even standard guideline dosing may not address caregiver dosing errors or readability issues. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) during the emergency department visit
Duration - Discharge day only
Participants are randomized to receive either a prescription with weight-based dosing for acetaminophen and ibuprofen or standardized printed discharge instructions without a prescription.
1 visit (in-person) at discharge from the emergency department
Duration - 7 days after discharge
Approximately one week after discharge, research personnel will contact participants to assess unscheduled return visits and parental satisfaction with emergency department care.
1 follow-up phone call
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Sandra Trapani, Adele Fiordelisi, Mariangela Stinco...
https://pubmed.ncbi.nlm.nih.gov/38255334/Section on Clinical Pharmacology and Therapeutics, Committee on Drugs, Janice E Sullivan...
https://pubmed.ncbi.nlm.nih.gov/21357332/University of Texas at Austin
Lead Sponsor